top of page

Annotated Reference List
Unit 5: Chronic Disease Prevention and Management

 

Alberta Government. (n.d.). healthanalytics.alberta.ca. Alberta.Ca. https://healthanalytics.alberta.ca/health-analytics.html

  • This website provides statistics and information about health demographics in the province of Alberta.

​

Bresee, L. C., Majumdar, S. R., Patten, S. B., & Johnson, J. A. (2010). Prevalence of cardiovascular risk factors and disease in people with

schizophrenia: A population-based study. Schizophrenia Research, 117(1), 75–82. https://doi.org/10.1016/j.schres.2009.12.016

  • This journal article identifies how schizophrenia and chronic diseases are interconnected, and provides statistics around correlation factors and demographics. 

 

Brown, L. C., Svenson, L. W., & Beck, C. a. (2009). Diabetes and mental health disorders in Alberta. Alberta Diabetes Atlas 2009}, 8, 113.

  • This journal article is specific to the prevalence of diabetes in individuals with mental health issues in Alberta.  It describes confounding variables and contributory factors.

​​

Government of Canada. (n.d.). chronic-disease-prevention-management @ www.canada.ca. Chronic Disease Prevention Management.

Retrieved March 3, 2022, from https://www.canada.ca/en/health-canada/services/health-care-system/reports-publications/primary-health-care/chronic-disease-prevention-management.html

  • The Government of Canada website that is specific to chronic disease and the Primary Health Care Transition Fund.  It outlines specifics of same, and a detailed description of how each province is affected.

 

Huo, L., Lu, X., Wu, F., Huang, X., Ning, Y., & Zhang, X. Y. (2021). Diabetes in late-life schizophrenia: Prevalence, factors, and association

with clinical symptoms. Journal of Psychiatric Research, 132(April 2020), 44–49. 

https://doi.org/10.1016/j.jpsychires.2020.09.026

  • A journal article specific to how Type 2 Diabetes impacts the aging population of individuals with schizophrenia.  Majority of research participants are Chinese patients.

​

Jørgensen, M., Mainz, J., Carinci, F., Thomsen, R. W., & Johnsen, S. P. (2018). Quality and predictors of diabetes care among patients With

schizophrenia: A Danish nationwide study. Psychiatric Services, 69(2), 179–185. https://doi.org/10.1176/appi.ps.201600460

  • A journal article that speaks to the quality of care differentiations of individuals with Type 2 Diabets and schizophrenia and those without.  Specific to the population of Denmark.

​

Mamakou, V., Thanopoulou, A., Gonidakis, F., Tentolouris, N., & Kontaxakis, V. (2018). Schizophrenia and type 2 diabetes mellitus.

Psychiatriki, 29(1), 64–73. Descriptive journal about the relationship between Type 2 Diabetes and Schizophrenia. 

  • Highlights incidents, occurrences, the effects of specific medications.

 

Mizuki, Y., Sakamoto, S., Okahisa, Y., Yada, Y., Hashimoto, N., Takaki, M., & Yamada, N. (2021). Mechanisms underlying the comorbidity

of schizophrenia and type 2 diabetes mellitus. International Journal of Neuropsychopharmacology, 24(5), 367–382. https://doi.org/10.1093/ijnp/pyaa097

  • The journal article attributes metabolic abnormalities such as Type 2 Diabetes to the prevalence of reduced life expectancies for those living with schizophrenia.

 

Ye, M., Vene, J. E., Johnson, J. A., Shen-Tu, G., & Eurich, D. T. (2016). Chronic disease surveillance in Alberta’s Tomorrow Project using Administrative Health Data. International Journal of Health Services, 46(4), 843–844. https://doi.org/10.1177/0020731416667333

  • This journal article provides in-depth understanding and data around the Alberta’s Tomorrow Project and how the program was created and implemented.  There is also significant amount of data on chronic disease in the province of Alberta from the results. 

bottom of page